Anti-oral cancer strategy by means of inhibition of cellular adhesion to extracellula matrices

通过抑制细胞与细胞外基质的粘附来抗口腔癌策略

基本信息

  • 批准号:
    10557170
  • 负责人:
  • 金额:
    $ 8.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

We have analyzed anti-cancer effect in a situation in which adhesion of oral carcinoma cells to extracellular matrices is inhibited. To this end, suramin, a polysulfonated naphthylurea, which has been used as an anti-trypanosoma reagent but has also known as an inhibitor of lysosomal heparanase, was used for inhibition of adhesion of oral carcinoma cells, such as ACC3 cells of human salivary adenoid cystic carcinoma origin.ACC3 cells have been known to biosynthesize excessive amounts of extracellular matrix (ECM) molecules, especially basement membrane-associated molecules, such as heparan sulfate proteoglycan, HSPG/perlecan, and fibronectin. When ACCE cess were cultivated in the presence of 100 ;uM suramin, secretion of ECM molecules by ACC3 cells into the culture medium was enhanced. When 200 fM suramin was added, attachment of ACC3 cells to culture dishes reduced significantly. In the presence of suramin and RGD peptides, which are an ECM recoginition site of integrins, the attachme … More nt was two times more inhibited. Thus, it was suggested that suramin affected integrih-dependent cell adhesion. By day 7 of culture in the presence of suramin, ECM molecules were shed more prominently into the culture medium of ACC3 cells. Immunofluorescence showed that ECM molecules and integrins were localized within the cytoplasm but not in the extracellular space or in the cell surface. These results indicated suramin inhibited cell membrane assembly of integrin and consequently trapping of ECM molecules by cell surface integrins.Immunoprecipitation and pulse-chase experi-ments showed that suramin inhibited biosynthesis of an unknown molecule with Mr. 120 kDa, which was co-precipitated with integrin a5. Immunoblotting experiments showed that the 120 kDa molecule was focal adhesion kinase (FAK), which functions in phospholylation of integrins. The results indicated that suramin inhibit FAK expression of ACC3 cells, which resulted in integrin function in cellular attachment.These results clearly indicate that the inhibition of cell surface receptors for ECM molecules can be one of the strategies for suppression of oral carcinoma cell growth. Less
我们分析了在抑制口腔癌细胞与细胞外基质粘附的情况下的抗癌效果。为此,苏拉明,一种多磺化萘脲,已被用作抗锥虫试剂,但也被称为溶酶体乙酰肝素酶的抑制剂,用于抑制口腔癌细胞的粘附,例如人唾液腺样囊性癌来源的ACC 3细胞。已知ACC 3细胞生物合成过量的细胞外基质(ECM)分子,特别是基底膜相关分子,例如硫酸乙酰肝素蛋白聚糖、HSPG/串珠素和纤连蛋白。当ACCE细胞在100 μ M苏拉明存在下培养时,ACC 3细胞向培养基中分泌ECM分子增强。当加入200 fM苏拉明时,ACC 3细胞对培养皿的附着显著减少。在苏拉明和RGD肽(它们是整联蛋白的ECM结合位点)存在下, ...更多信息 NT是两倍多的抑制。因此,这表明苏拉明影响整合依赖性细胞粘附。到苏拉明存在下培养的第7天,ECM分子更显著地脱落到ACC 3细胞的培养基中。免疫荧光显示,ECM分子和整合素定位在细胞质内,但不在细胞外空间或细胞表面。免疫沉淀和脉冲追踪实验表明,苏拉明抑制了整合素α 5与一个分子量为120 kDa的未知分子的生物合成。免疫印迹实验表明,120 kDa的分子是粘着斑激酶(FAK),其功能在整合素的磷酸化。结果表明,苏拉明抑制ACC 3细胞FAK的表达,从而使整合素在细胞粘附中发挥作用,抑制细胞表面ECM分子的受体可能是抑制口腔癌细胞生长的策略之一。少

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Munakata, R.et al.: "Spindle cell carcinoma of the gingiva." Journal of Oral Pathology & Medicine. 27. 180-184 (1998)
Munakata, R.et al.:“牙龈梭形细胞癌”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ono, Y.et al.: "Vascular invasion of O-1N, hamster squamous cell carcinoma with high potential of lymph node metastasis: Ultrastrucutural comparison between lymphatics and blood vessels." Pathology International. 48. 254-264 (1998)
Ono, Y. 等人:“O-1N 仓鼠鳞状细胞癌的血管侵犯,具有高淋巴结转移潜力:淋巴管和血管之间的超结构比较。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toyoshima, K. et al.: "High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin."Japanese Journal of Cancer Research. 90. 308-319 (1999)
Toyoshima, K. 等人:“唾液腺腺样囊性癌细胞合成的高分子量纤连蛋白。”日本癌症研究杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Irie, T. et al.: "Intracellular transport of basement membrane-type heparan sulfate proteoglycan in adenoid cystic carcinoma cells of salivary gland origin: an immunoelectron microscopic study"Virchows Arch. 433(1). 41-48 (1998)
Irie, T. 等人:“唾液腺起源的腺样囊性癌细胞中基底膜型硫酸乙酰肝素蛋白多糖的细胞内转运:免疫电子显微镜研究”Virchows Arch。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kimura, S. et al: "Basement membrane heparan suifate proteoglycan (perlecan) synthesized by ACC, adenoid cystic carcinoma cell of human salivary gland origin"Journal of Biochemistry. 25(2). 406-413 (1999)
Kimura, S.等人:“ACC(人唾液腺来源的腺样囊性癌细胞)合成的基底膜硫酸乙酰肝素蛋白聚糖(perlecan)”生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKU Takashi其他文献

SAKU Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKU Takashi', 18)}}的其他基金

Molecular pathways and functional varieties of hemophagocytosis-induced keratinization in oral squamous cell carcinoma cells: from cell death to proliferation and invasion
口腔鳞状细胞癌细胞噬血作用诱导角化的分子途径和功能多样性:从细胞死亡到增殖和侵袭
  • 批准号:
    15K15693
  • 财政年份:
    2015
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Pathogenesis of oral cancer due to chewing habits spread in Asia to East Africa
咀嚼习惯引起的口腔癌发病机制从亚洲传播到东非
  • 批准号:
    19406030
  • 财政年份:
    2007
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular and pathology analyses for switching mechanism of stromal inducement in invasive oral carcinoma
侵袭性口腔癌基质诱导转换机制的分子和病​​理学分析
  • 批准号:
    18390486
  • 财政年份:
    2006
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular pathological analysis of oral carcinoma caused by chewing habits in Asia
亚洲咀嚼习惯所致口腔癌的分子病理学分析
  • 批准号:
    15256005
  • 财政年份:
    2003
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
A new anti-cancer strategy by control ling crosstalk of oral carcinoma cells with extracellular matrix molecules
控制口腔癌细胞与细胞外基质分子串扰的抗癌新策略
  • 批准号:
    14370581
  • 财政年份:
    2002
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A new anti-cancer strategy by control ling cross talk of oral carcinoma cells with extra cellular matrix molecules
控制口腔癌细胞与细胞外基质分子串扰的新抗癌策略
  • 批准号:
    13557157
  • 财政年份:
    2001
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular biologic and pathologic study of Epstein-Barr virus infected lymphepithalial carcinomas in salivary gland
EB病毒感染唾液腺淋巴上皮癌的分子生物学和病理学研究
  • 批准号:
    12576024
  • 财政年份:
    2000
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A variety of molecular crosstalks between extracellular matrices and their cell surface receptors in oral carcinomas
口腔癌细胞外基质与其细胞表面受体之间的各种分子串扰
  • 批准号:
    10470379
  • 财政年份:
    1998
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Epstein-Barr virus infection in Chinese salivary cancers
中国唾液癌中的 Epstein-Barr 病毒感染
  • 批准号:
    08042003
  • 财政年份:
    1996
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Stromal remodeling in processes of proliferation, invasion and metastasis of oral carcinoma cells : a molecular pathological study
口腔癌细胞增殖、侵袭和转移过程中的基质重塑:分子病理学研究
  • 批准号:
    08457477
  • 财政年份:
    1996
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Heparan sulfate proteoglycan in the brain vascular clearance of amyloid-β and Alzheimer's disease
硫酸乙酰肝素蛋白多糖在脑血管清除淀粉样蛋白-β 和阿尔茨海默氏病中的作用
  • 批准号:
    10301892
  • 财政年份:
    2021
  • 资助金额:
    $ 8.77万
  • 项目类别:
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
硫酸乙酰肝素蛋白多糖结合病原体的糖聚合物抑制剂
  • 批准号:
    10684252
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
硫酸乙酰肝素蛋白多糖结合病原体的糖聚合物抑制剂
  • 批准号:
    10491359
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
硫酸乙酰肝素蛋白多糖结合病原体的糖聚合物抑制剂
  • 批准号:
    10333201
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
In vitro investigation of (pro)IAPP binding to heparan sulfate proteoglycan
(pro)IAPP 与硫酸乙酰肝素蛋白聚糖结合的体外研究
  • 批准号:
    358571-2008
  • 财政年份:
    2011
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
In vitro investigation of (pro)IAPP binding to heparan sulfate proteoglycan
(pro)IAPP 与硫酸乙酰肝素蛋白聚糖结合的体外研究
  • 批准号:
    358571-2008
  • 财政年份:
    2010
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Collagen X and heparan sulfate proteoglycan in the hematopoietic stem cell niche.
造血干细胞生态位中的 X 胶原蛋白和硫酸乙酰肝素蛋白多糖。
  • 批准号:
    8326237
  • 财政年份:
    2010
  • 资助金额:
    $ 8.77万
  • 项目类别:
Collagen X and heparan sulfate proteoglycan in the hematopoietic stem cell niche.
造血干细胞生态位中的 X 胶原蛋白和硫酸乙酰肝素蛋白多糖。
  • 批准号:
    8146158
  • 财政年份:
    2010
  • 资助金额:
    $ 8.77万
  • 项目类别:
Collagen X and heparan sulfate proteoglycan in the hematopoietic stem cell niche.
造血干细胞生态位中的 X 胶原蛋白和硫酸乙酰肝素蛋白多糖。
  • 批准号:
    7989286
  • 财政年份:
    2010
  • 资助金额:
    $ 8.77万
  • 项目类别:
In vitro investigation of (pro)IAPP binding to heparan sulfate proteoglycan
(pro)IAPP 与硫酸乙酰肝素蛋白聚糖结合的体外研究
  • 批准号:
    358571-2008
  • 财政年份:
    2009
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了